Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

BXP, Inc. (BXP) SEC Filings & Earnings Calls

EquiReason read 13 BXP, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-31 — BXP issued $700M 6.050% Senior Notes due 2036, net proceeds ~$692.4M, to refinance $1B 2.750% notes due Oct 2026. Refinancing extends maturity and locks in higher coupon..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

REIT - Office · Real Estate
—
Price chart with a free account
Market cap
9.9B
P/E TTM
—
Dividend yield
5.5%
52-week
—
Next earnings
27 Oct, in 3 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

31 Aug 20268-K · 8.01BXP issued $700M 6.050% Senior Notes due 2036, net proceeds ~$692.4M, to refinance $1B 2.750% notes due Oct 2026. Refinancing extends maturity and locks in higher coupon.open

Risks flagged

Higher coupon increases interest expense; refinancing risk partially mitigated by extending maturity.

“6.050% Senior Notes due 2036 replace 2.750% notes due 2026”
Read the original on SEC EDGAR ↗
6 Aug 202610-QTotal Portfolio Occupancy 88.4; Total Portfolio Leased Percentage 91.3; Same Property NOI Growth 2.77; Guidance: Occupancy trajectory ahead of Investor Day targets; 1.3M sq ft lease backlog, 85% to commence by year-endopen

Figures in the filing · each found in the filing text

Total Portfolio Occupancy · Q2-202688.4%
Total Portfolio Leased Percentage · Q2-202691.3%
Same Property NOI Growth · H1-20262.8%
Same Property Occupancy · H1-202689.1%
Net Sale Proceeds (Year-to-Date) · 2026$432M
Weighted Average Lease Term (Executed Leases) · Q2-2026$9.90
Second Generation Cash Rent Change · Q2-20261.6%

Guidance

Occupancy trajectory ahead of Investor Day targets; 1.3M sq ft lease backlog, 85% to commence by year-end

Management raised occupancy trajectory guidance, citing strong leasing pipeline and constructive demand for premier workplaces.

Risks flagged

Life Science Leasing Demand Below Historical Levels

“Life science leasing demand remains below historical levels, particularly among earlier-stage companies” · word for word

Elevated Financing Costs and Economic Uncertainty

“elevated financing costs and broader economic uncertainty continue to influence real estate investment and occupier decision-making” · word for word

West Coast Market Weakness

“San Francisco second-gen cash rents -17.76%, Seattle -20.11%”
Read the original on SEC EDGAR ↗
28 Jul 20268-K · 2.02BXP reported Q2 2026 revenue up 3.1% to $895.7M, FFO per share $1.78 vs $1.71 prior year, occupancy up 100 bps to 88.4%, and raised full-year FFO guidance midpoint by $0.05.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$896M+3% y/y
Net income attributable to BXP, Inc. · Q2-2026$69M-23% y/y
FFO per diluted share · Q2-2026$1.78+4% y/y
Total portfolio occupancy · Q2-202688.4%
Total portfolio leased percentage · Q2-202691.3%
CBD portfolio occupancy · CBD · Q2-202690.7%
CBD portfolio leased percentage · CBD · Q2-202693.6%
Weighted-average lease term · Q2-2026$9.90
EPS (diluted) · Q2-2026$0.43-23% y/y

Guidance

Q3 2026 EPS $0.50-$0.52, FFO $1.80-$1.82; FY2026 EPS $2.14-$2.24 (midpoint down $0.03), FFO $6.99-$7.05 (midpoint up $0.05)

Full-year FFO guidance raised due to better portfolio performance; EPS guidance slightly lowered due to impairment but operating performance improved.

Risks flagged

Impairment charge on Sumner Square disposition

“EPS for Q2 2026 was less than midpoint by $0.02 due to a $0.10 non-cash impairment charge on anticipated disposition of Sumner Square in Washington, DC.”

Office demand uncertainty in non-CBD markets

“Total portfolio occupancy at 88.4% vs CBD at 90.7%, indicating suburban/other markets may be weaker.”
Read the original on SEC EDGAR ↗
29 May 20268-K · 2.06Impairment loss $18M; EPS impact per diluted share $0.10; Gross sale price $63Mopen

Figures in the filing · each found in the filing text

Impairment loss · Washington DC · Q2-2026$18M
EPS impact per diluted share · Q2-2026$0.10
Gross sale price · Washington DC · Q2-2026$63M
Non-refundable deposit · Q2-2026$6M

Risks flagged

Washington DC office market weakness leading to impairment on planned sale.

“$18M impairment; sale price $63M; property in Washington DC.”

Sale not guaranteed; may not close on terms.

“There can be no assurance that the sale will be consummated.” · word for word
Read the original on SEC EDGAR ↗
7 May 202610-QTotal Portfolio Occupancy 87.4; Total Portfolio Leased Percentage 90.9; Net Sale Proceeds (Year-to-Date) $358M; Guidance: Year-end 2026 occupancy targets consistent with September 2025 Investor Day; 1.6M sq ft lease backlog, 91% to commenceopen

Figures in the filing · each found in the filing text

Total Portfolio Occupancy · Q1-202687.4%
Total Portfolio Leased Percentage · Q1-202690.9%
Net Sale Proceeds (Year-to-Date) · 2026$358M
Weighted Average Lease Term (Executed Leases) · Q1-2026$8.70
Second Generation Cash Rent Change · Q1-2026-3.2%
FFO attributable to BXP, Inc. · Q1-2026$252M-3% y/y

Guidance

Year-end 2026 occupancy targets consistent with September 2025 Investor Day; 1.6M sq ft lease backlog, 91% to commence in 2026

Management reaffirmed occupancy targets for year-end 2026, citing strong leasing pipeline and constructive demand.

Risks flagged

West Coast Market Weakness

“Second-gen cash rents negative in Boston, New York, DC; positive in San Francisco and Seattle but from low base”

Elevated Financing Costs and Economic Uncertainty

“elevated financing costs and broader economic uncertainty continue to influence real estate investment and occupier decision-making”
Read the original on SEC EDGAR ↗
28 Apr 20268-K · 2.02Revenue $872M (+1% y/y); Net income attributable to BXP, Inc. $102M (+66% y/y); EPS $0.64 (+64% y/y); Guidance: Full year 2026 FFO guidance midpoint increased by $0.01 to $6.97 per shareearningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$872M+1% y/y
Net income attributable to BXP, Inc. · Q1-2026$102M+66% y/y
EPS · Q1-2026$0.64+64% y/y
FFO per diluted share · Q1-2026$1.59-3% y/y
Total portfolio occupancy · Q1-202687.4%
Total portfolio leased percentage · Q1-202690.9%
CBD portfolio occupancy · CBD · Q1-202689.9%
CBD portfolio leased percentage · CBD · Q1-202693.4%
Square feet of leases executed · Q1-20261,100,000
Weighted-average lease term · Q1-2026$8.70

Guidance

Full year 2026 FFO guidance midpoint increased by $0.01 to $6.97 per share

Q1 FFO beat; full-year FFO guidance raised slightly; leasing momentum and asset sales support outlook.

Risks flagged

Commercial real estate market conditions remain uncertain; occupancy still below pre-pandemic levels.

“Total portfolio occupancy 87.4%”
Read the original on SEC EDGAR ↗
10 Apr 2026DEF 14ATotal Target Compensation (CEO) $14M; Total Target Compensation (President) $10M; Total Target Compensation (CFO) $5Mopen

Figures in the filing · each found in the filing text

Total Target Compensation (CEO) · FY2025$14M
Total Target Compensation (President) · FY2025$10M
Total Target Compensation (CFO) · FY2025$5M
Total Target Compensation (Boston EVP) · FY2025$3M
Total Target Compensation (NY EVP) · FY2025$3M
Square Feet Leased · FY20255,600,000
Occupancy Rate · Q4-202586.7%
Asset Sales Net Proceeds (BXP Share) · FY2025$848M
Debt Market Activities Total · FY2025$5.30B
CEO Actual Annual Cash Incentive · FY2025$3M

Risks flagged

Commercial Real Estate Headwinds

“the headwinds impacting the commercial real estate industry (e.g., continued inflation, elevated interest rates, etc.)” · word for word

Office Sector Demand Weakness

“the expectation of continued weakened supply and demand fundamentals in our West Coast markets at the time the targets were set” · word for word

Leverage and Development Funding Risk

“strategic action plan, which aims to increase FFO per Share, fund development costs and reduce leverage over the next few years” · word for word

Shareholder Compensation Disapproval Risk

“The 67.5% support level for the 2024 Say-on-Pay proposal did not meet our expectations” · word for word
Read the original on SEC EDGAR ↗
6 Mar 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportSEC ↗
27 Feb 202610-KExecuted Leases Sqft 5,600,000; Net Proceeds Sale YTD $170Mopen

Figures in the filing · each found in the filing text

Executed Leases Sqft · FY20255,600,000
Net Proceeds Sale YTD · FY2025$170M

Risks flagged

Office market impairment risk

“For the year ended December 31, 2025, BXP and BPLP recognized impairments of long-lived assets of approximately $85.8 million and $82.9 million, respectively, and one of our investments in an unconsolidated joint venture recognized an 'other than temporary' impairment of approximately $145.1 million.” · word for word

Asset sales execution risk

“Any such inability to dispose of certain assets on the timelines we anticipate or on terms that are favorable to us, or at all, could negatively impact the proceeds we expect the multi-year asset sales program to generate, and accordingly, could adversely affect our financial condition and results of operations.” · word for word
Read the original on SEC EDGAR ↗
28 Jan 20268-K · 2.02Revenue $877M (+2% y/y); Net income attributable to BXP $248M; FFO per diluted share $1.76 (-2% y/y); Guidance: FY2026 FFO $6.88-$7.04 per shareearningsopen

Figures in the filing · each found in the filing text

Revenue · Q4-2025$877M+2% y/y
Net income attributable to BXP · Q4-2025$249M
FFO per diluted share · Q4-2025$1.76-2% y/y
Total portfolio occupancy · Q4-202586.7%
Leased percentage (total portfolio) · Q4-202589.4%
Executed leases square footage · Q4-20251,800,000
Full year FFO per diluted share · FY2025$6.85-4% y/y
Full year net income attributable to BXP · FY2025$277M

Guidance

FY2026 FFO $6.88-$7.04 per share

Guidance implies modest FFO growth; assumptions include higher occupancy and NOI from developments.

Risks flagged

Non-cash straight-line rent reserves

“FFO missed guidance midpoint due to $0.05 from non-cash straight-line rent reserves related to two clients.”

Higher G&A costs

“Higher G&A expense of $0.07 per share in 2026 guidance, primarily non-cash amortization.” · word for word
Read the original on SEC EDGAR ↗
22 Dec 20258-K · 5.02, 7.01OPP-related compensation expense (total) $32M; OPP-related compensation expense (2026) $12M; OPP-related compensation expense per share (2026) $0.07open

Figures in the filing · each found in the filing text

OPP-related compensation expense (total) · FY2026-FY2029$32M
OPP-related compensation expense (2026) · FY2026$12M
OPP-related compensation expense per share (2026) · FY2026$0.07
stock price target (minimum) · FY2026-FY2029$90.00
stock price target (maximum) · FY2026-FY2029$118.00

Risks flagged

No material risks identified beyond standard executive compensation.

“No disagreement or operational issues cited.”
Read the original on SEC EDGAR ↗
7 Nov 202510-QBXP reported Q3 2025 results with strong leasing activity (+39% YoY) but slight occupancy decline; no explicit beat or miss stated.earningsopen

Figures in the filing · each found in the filing text

Leases executed (sq ft) · Q3-20251,524,198+39% y/y
Occupancy · Q3-202586.0%
Leased percent · Q3-202588.8%
Net Operating Income (NOI) · 9M-2025$1.54B+1% y/y
Same Property NOI · 9M-2025$1.49B+0% y/y
Development pipeline BXP investment · Q3-2025$3.90B

Risks flagged

Occupancy decline from new developments

“At September 30, 2025, our total portfolio occupancy for the third quarter was 86.0%, a decrease of 40 basis points from the second quarter of 2025.” · word for word

Impairment losses on non-core assets

“Impairment losses ... $68,901 ... $13,615 ... $55,286 ... 406.07%”

Negative rent growth on second-gen leases

“Increase (Decrease) in Net Rents ... (7.13)%”
Read the original on SEC EDGAR ↗
28 Oct 20258-K · 2.02Revenue $872M (+1% y/y); Net income (loss) attributable to BXP $-122M; EPS (diluted) $-0.77; Guidance: FY2025 EPS $0.99-$1.02, FFO $6.89-$6.92 per shareearningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$872M+1% y/y
Net income (loss) attributable to BXP · Q3-2025$-122M
EPS (diluted) · Q3-2025$-0.77
Funds from Operations (FFO) per diluted share · Q3-2025$1.74-4% y/y
Occupancy (CBD portfolio) · CBD · Q3-202589.3%
Leased percentage (CBD portfolio) · CBD · Q3-202592.0%
Executed leases square feet · Q3-20251,500,000+38% y/y
Weighted-average lease term · Q3-2025$7.90
Portfolio occupancy (ex-development) · Q3-202586.6%
Portfolio leased percentage (ex-development) · Q3-202589.2%

Guidance

FY2025 EPS $0.99-$1.02, FFO $6.89-$6.92 per share

Guidance reaffirmed with FFO beat; EPS impacted by impairments. Leasing momentum strong, development pipeline active.

Risks flagged

Impairment charges from strategic asset sales program

“non-cash impairment charges totaling $1.22 per diluted share related to our strategic asset sales program” · word for word

Occupancy decline including development deliveries

“total portfolio occupancy rate for the third quarter was 86.0%, a decrease of 40 basis points from Q2 2025” · word for word

Uncertainty in asset sale timing and completion

“There can be no assurance that BXP will sell these properties on the terms or the schedule currently contemplated.” · word for word
Read the original on SEC EDGAR ↗

BXP, Inc. — questions

What did BXP, Inc. file recently?
13 SEC filings in the last 12 months. Latest: 8-K on 2026-08-31 — BXP issued $700M 6.050% Senior Notes due 2036, net proceeds ~$692.4M, to refinance $1B 2.750% notes due Oct 2026. Refinancing extends maturity and locks in higher coupon.

Every figure on this page comes from BXP, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.